The store will not work correctly when cookies are disabled.
5-tert-Butyl-N-p-tolylpyrazine-2-carboxamide
ID: ALA498409
PubChem CID: 24881805
Max Phase: Preclinical
Molecular Formula: C16H19N3O
Molecular Weight: 269.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(NC(=O)c2cnc(C(C)(C)C)cn2)cc1
Standard InChI: InChI=1S/C16H19N3O/c1-11-5-7-12(8-6-11)19-15(20)13-9-18-14(10-17-13)16(2,3)4/h5-10H,1-4H3,(H,19,20)
Standard InChI Key: LDNMSSQGDLSKBQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
11.2986 -19.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2974 -20.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0122 -20.4527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7287 -20.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7258 -19.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0104 -18.7997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4387 -18.7936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1547 -19.2034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4356 -17.9686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8677 -18.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5821 -19.2015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2945 -18.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2918 -17.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5708 -17.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8613 -17.9683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5826 -20.4518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8625 -20.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9914 -21.1684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1756 -19.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0042 -17.5449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 10 1 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
2 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
4 5 1 0
13 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.35 | Molecular Weight (Monoisotopic): 269.1528 | AlogP: 3.33 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -1.61 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |